79079325 - ACLARUSDX

Information

  • Trademark
  • 79079325
  • Serial Number
    79079325
  • Registration Number
    4021169
  • Filing Date
    November 24, 2009
    15 years ago
  • Registration Date
    September 06, 2011
    13 years ago
  • Transaction Date
    December 13, 2020
    4 years ago
  • Status Date
    November 24, 2019
    5 years ago
  • Published for Opposition Date
    June 21, 2011
    13 years ago
  • Location Date
    December 05, 2014
    10 years ago
Mark Drawing Code
5000
Mark Identification
ACLARUSDX
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Chemicals and chemical compositions, namely, nucleic acids attached to a solid support for use in industry and science; analyses, namely, reagent for chemical analyses, namely, quantification of nucleic acid content in laboratories chemical preparations for analyses, other than for medical or veterinary use; biological preparations, namely, quantification of nucleic acid content other than for medical or veterinary use, namely, inoculants, namely, biological microorganisms used in fermentation of silage; chemical preparations for scientific use, other than for medical or veterinary use; chemical preparations or reagents for laboratory, other than for medical or veterinary use; chemical preparations for scientific use, namely, nucleic acid libraries to screen and analyze gene expression, to identify therapeutic targets and products, and to conduct pharmacogenomic and genotoxicity research in the fields of pharmacology, food, chemistry, cosmetology, plant protection, and veterinary sciences; chemical preparations for scientific use, namely, DNA biochips for decoding genes affected by the Alzheimer's disease or revealing the transcriptomic signature of patients affected with Alzheimer's disease, and DNA chips to make visible and analyze gene expression in the fields of human and pharmacological medicine and veterinary science
  • GS0051: Pharmaceutical preparations for treating neurodegenerative diseases and particularly Alzheimer's disease; tests, namely, a blood based biomarker test to identify patients with Alzheimer's disease or at risk of developing the disease and identifying patients responding to specific treatments; biological products and preparations acids for pharmaceutical use, namely, pharmaceutical preparations for the diagnostic of the Alzheimer's disease; capsules sold empty for medicines and diagnostic tests; chemical-pharmaceutical preparations for the diagnosis, the prevention or the treatment of Alzheimer's disease; biopharmaceutical preparations for the diagnosis, the prevention or the treatment of Alzheimer's disease; chemical preparations for medical, pharmaceutical or veterinary use, namely, for diagnosing neurodegenerative diseases and particularly Alzheimer's disease; medical and clinical diagnostic products, namely, probe sets, namely, subset of nucleic acid sequences and nucleic acid libraries, namely, DNA libraries and RNA libraries; nucleic acid sequences for use on biochips, namely, for decoding genes affected by the Alzheimer's disease or revealing the transcriptomic signature of patients affected with Alzheimer's disease; enzymes or enzyme preparations for medical or veterinary use, namely, enzymes stabilizers, namely, enzymes for medical purposes or veterinary use, namely, for treatment of Alzheimer's disease, enzyme substrates, namely, enzymes for medical purposes or veterinary use, namely, for treatment of Alzheimer's disease used as an ingredient in drugs against Alzheimer's disease
  • GS0101: Surgical, medical, dental and veterinary apparatus and instruments, namely, for disease identification, measure of disease severity, measure of disease prognosis, measure of disease progression, measure of disease conversion; medical devices, namely, biochips for analysis of blood; blood testing apparatus; devices, namely, biochips for medical diagnostics uses, namely, biochips for diagnosing Alzheimer's disease, namely, collection kit for blood sampling to perform the test in the right conditions; spoons for administering medicine; receptacles for applying medicines; ultrasound probes for medical use; syringes for medical use; galvanic therapeutic medical devices to diagnose neurodegenerative diseases and particularly Alzheimer's disease
  • GS0421: Research and development for third parties in relation to pharmaceutical molecules or biological markers, medicines for the diagnosis and treatment of neurodegenerative diseases; chemical analysis; chemical research; chemical services, namely, analysis of RNA, genes, tissue and blood sample; biotechnology project studies, namely, identifying population of patients affected by the Alzheimer disease and measuring the disease's severity, prognosis, progression and conversion and determining patients sensitivity to treatment; research and development of new products for third parties; biological research; research in biotechnology; technical research in the field of biotechnology; biotechnology analysis services
  • GS0441: Medical services; veterinary services; medical assistance services; providing medical information, consultancy and advisory services; hospital services; pharmacists' services relating to the pharmaceutical industry, namely, the filling of and making up prescriptions; health care; telemedicine services
Case File Event Statements
  • 12/12/2020 - 4 years ago
    48 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED Type: DENC
  • 12/12/2020 - 4 years ago
    47 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH
  • 9/25/2015 - 9 years ago
    46 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 9/2/2015 - 9 years ago
    45 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS
  • 9/2/2015 - 9 years ago
    44 - INVALIDATION PROCESSED Type: INPC
  • 8/5/2015 - 9 years ago
    43 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 12/5/2014 - 10 years ago
    42 - CANCELLED SECTION 7-TOTAL Type: C7..
  • 12/5/2014 - 10 years ago
    41 - CANCELLATION TERMINATED NO. 999999 Type: CANT
  • 12/3/2014 - 10 years ago
    40 - CANCELLATION DENIED NO. 999999 Type: CAND
  • 10/24/2014 - 10 years ago
    39 - CANCELLATION INSTITUTED NO. 999999 Type: PETC
  • 5/19/2013 - 11 years ago
    38 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 3/8/2012 - 12 years ago
    37 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 3/8/2012 - 12 years ago
    36 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 12/18/2011 - 13 years ago
    35 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 12/6/2011 - 13 years ago
    34 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 10/15/2011 - 13 years ago
    33 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 9/6/2011 - 13 years ago
    32 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/3/2011 - 13 years ago
    31 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 8/17/2011 - 13 years ago
    30 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 8/17/2011 - 13 years ago
    29 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 6/21/2011 - 13 years ago
    28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/21/2011 - 13 years ago
    27 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/1/2011 - 13 years ago
    26 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 6/1/2011 - 13 years ago
    25 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 5/19/2011 - 13 years ago
    24 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 5/19/2011 - 13 years ago
    23 - ASSIGNED TO LIE Type: ALIE
  • 5/6/2011 - 13 years ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/8/2011 - 13 years ago
    21 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/8/2011 - 13 years ago
    20 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/8/2011 - 13 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/8/2011 - 13 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/8/2011 - 13 years ago
    17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 8/9/2010 - 14 years ago
    16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 8/9/2010 - 14 years ago
    15 - FINAL REFUSAL E-MAILED Type: GNFR
  • 8/9/2010 - 14 years ago
    14 - FINAL REFUSAL WRITTEN Type: CNFR
  • 7/12/2010 - 14 years ago
    13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/12/2010 - 14 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/12/2010 - 14 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/12/2010 - 14 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/30/2010 - 14 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/19/2010 - 14 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/19/2010 - 14 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/19/2010 - 14 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/19/2010 - 14 years ago
    5 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/18/2010 - 14 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/15/2010 - 14 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/15/2010 - 14 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/11/2010 - 14 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR